Editor / Curator | Internet | Biotech Stock Review | Page 39

Home Authors Posts by Editor / Curator

390 POSTS 0 COMMENTS

Roland Rick Perry, Biotech Stock Review

Biotech News

CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground...

Editor / Curator - September 2, 2015

Video

Zestra® Female Sexual Arousal on ABC’s “The View.”

Editor / Curator - August 20, 2013

zestra, biotech stock review

eCommerce

Innovus (INNV) Zestra® Female Sexual Arousal Oils Featured in NY Times.

Editor / Curator - July 2, 2012

Biotech Stock Review

Health $ Fitness

Christopher E. Rivera Appointed to the Council of Washington Biotechnology &...

Editor / Curator - June 27, 2011

All News

Adding VirnetX (VHC) $6.50 To Watch List.

Editor / Curator - June 10, 2010

Research

Circle Group / Z-Trim (CRGQ/ZTRM) $2.50. Report.

Editor / Curator - September 3, 2003

Research

Circle Group Holdings (CRGQ) $0.47 Report.

Editor / Curator - March 19, 2003

Internet Stock Review

Research

Adding the Jackson Family’s Modern Records (MDNR) to Watch List.

Editor / Curator - December 13, 2000

Video

Revelers United. And One Day We Shall Rule the World!

Editor / Curator - April 22, 1958

Revelers.IO

Video

Revelers Unite. So That One Day, We Shall Rule The World.

Editor / Curator - April 4, 1958

1...37 3839Page 39 of 39

Latest article

Wall Street Pounces on Hydroponics.

All News Editor / Curator - February 22, 2021

Indoor Growing & Hydroponics Outperform Both the Market and Marijuana Sector. Investor attention is...

Another Look at the Snowflake (SNOW) Mega IPO.

Internet News Editor / Curator - February 19, 2021

We haven't looked at Snowflake (SNOW) since its amazing IPO debut. It was priced at $120 and opened for trading at $245...

Wall Street Showing Love. Hepion Pharma (HEPA), Citius Pharma (CTXR) Raise $166 Million.

Biotech News Editor / Curator - February 17, 2021

Hepion (HEPA) Banked $88 Million Yesterday, Citius (CTXR) Banks $78 Million Today. We're beginning to believe (and...

The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062